Many investors hope to win big on biotech stocks as shares can sky rocket when there is good news. Analysts explain why there are plenty …
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies, climbed nearly 3% today, four-day win streak, helped by some encouraging …
Cytokinetics, Inc. (NASDAQ:CYTK) reported total research and development revenues for the fourth quarter of 2015 were $9.
Amazon.com,Inc.
Cytokinetics, Inc. (NASDAQ:CYTK) announced that results from the expansion phase of COSMIC-HF (ChronicOral Study of Myosin Activation to Increase Contractility in Heart Failure), a …
Cytokinetics, Inc. (NASDAQ:CYTK) reported total research and development revenues for the third quarter of 2015 were $7.
Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc.
Analysts weigh in on the biopharmaceutical company Merrimack Pharmaceuticals Inc (NASDAQ:MACK) and biotechnology company Cytokinetics, Inc. (NASDAQ:CYTK), with positive ratings and views.
Recently, various executives have taken part in insider buying activity for the stocks of Tesla Motors Inc (NASDAQ:TSLA), SolarCity Corp (NASDAQ:SCTY), Cytokinetics, Inc. (NASDAQ:CYTK), and Halozyme …
In a research report published Thursday, Roth Capital analyst Joseph Pantginis maintained a Buy rating on shares of Cytokinetics, Inc. (NASDAQ:CYTK) with a price target …
